Document Detail


Hypoxia-targeted radiotherapy dose painting for head and neck cancer using (18)F-FMISO PET: A biological modeling study.
MedLine Citation:
PMID:  23317145     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background. This study investigates the use of (18)F-fluoromisonidazole (FMISO) PET-guided radiotherapy dose painting for potentially overcoming the radioresistant effects of hypoxia in head and neck squamous cell carcinoma (HNSCC). Material and methods. The study cohort consisted of eight patients with HNSCC who were planned for definitive radiotherapy. Hypoxic subvolumes were automatically generated on pre-radiotherapy FMISO PET scans. Three radiotherapy plans were generated for each patient: a standard (STD) radiotherapy plan to a dose of 70 Gy, a uniform dose escalation (UDE) plan to the standard target volumes to a dose of 84 Gy, and a hypoxia dose-painted (HDP) plan with dose escalation only to the hypoxic subvolume to 84 Gy. Plans were compared based on tumor control probability (TCP), normal tissue complication probability (NTCP), and uncomplicated tumor control probability (UTCP). Results. The mean TCP increased from 73% with STD plans to 95% with the use of UDE plans (p < 0.001) and to 93% with HDP plans (p < 0.001). The mean parotid NTCP increased from 26% to 44% with the use of UDE plans (p = 0.003), and the mean mandible NTCP increased from 2% to 27% with the use of UDE plans (p = 0.001). There were no statistically significant differences between any of the NTCPs between the STD plans and HDP plans. The mean UTCP increased from 48% with STD plans to 66% with HDP plans (p = 0.016) and dropped to 37% with UDE plans (p = 0.138). Conclusion. Hypoxia-targeted radiotherapy dose painting for head and neck cancer using FMISO PET is technically feasible, increases the TCP without increasing the NTCP, and increases the UTCP. This approach is superior to uniform dose escalation.
Authors:
Joe H Chang; Morikatsu Wada; Nigel J Anderson; Daryl Lim Joon; Sze Ting Lee; Sylvia J Gong; Dishan H Gunawardana; John Sachinidis; Graeme O'keefe; Hui K Gan; Vincent Khoo; Andrew M Scott
Related Documents :
7695475 - New no-donors with antithrombotic and vasodilating activities, x: antiplatelet and anti...
9801975 - Complement activation during major surgery: the effect of extracorporeal circuits and h...
18481235 - Current activity guidelines for cabg patients are too restrictive: comparison of the fo...
8202985 - Chimeric 7e3 prevents carotid artery thrombosis in cynomolgus monkeys.
2965425 - Effect of inhaled formyl-methionyl-leucyl-phenylalanine on airway function.
12023525 - Cb1 receptors in the preoptic anterior hypothalamus regulate win 55212-2 [(4,5-dihydro-...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-15
Journal Detail:
Title:  Acta oncologica (Stockholm, Sweden)     Volume:  -     ISSN:  1651-226X     ISO Abbreviation:  Acta Oncol     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8709065     Medline TA:  Acta Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Radiation Oncology Centre , Austin Health, Victoria , Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ethnic differences in breast cancer risk and survival: A study on immigrants in Sweden.
Next Document:  Autologous canine red blood cell transfusion using cell salvage devices.